Sysmex (6869) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 Aug, 2025Executive summary
Net sales fell 5.6% year-over-year to ¥105.7 billion, operating profit dropped 36.5%, and profit attributable to owners declined 58.7%, mainly due to yen appreciation and a core system transition in Japan.
Restricted order intake from the system transition reduced net sales by ¥3.3 billion and gross profit by ¥2.4 billion.
Overseas sales declined 3.6% due to weaker demand and currency effects; Japan sales dropped 19.7% amid lower reagent and instrument sales.
SG&A expenses rose 6.3% due to business expansion and digital investments, while R&D expenses decreased 12.9% as major projects concluded.
Net sales increased year-over-year on a local currency basis outside Japan and China; China saw a 5% local currency decline due to healthcare cost controls.
Financial highlights
Operating profit for the quarter was ¥10.6 billion, down from ¥16.7 billion year-over-year; profit attributable to owners was ¥4.5 billion, down 58.7%.
Basic earnings per share decreased to ¥7.30 from ¥17.69 year-over-year.
Forex impact: sales -¥5.5 billion, SG&A -¥1.34 billion, operating profit +¥0.71 billion.
Inventory revaluation overseas and system transition in Japan negatively impacted operating profit by ¥7.4 billion and ¥3.0 billion, respectively.
Foreign exchange loss of ¥1.5 billion contributed to the profit decline.
Outlook and guidance
Full-year net sales forecast is ¥535.0 billion (up 5.2%), with operating profit projected at ¥91.5 billion (up 4.5%) and EPS at ¥91.40.
Six-month forecast revised: net sales ¥240.0 billion (up 1.0%), operating profit ¥36.0 billion (down 19.1%).
Full-year targets expected to be met by strengthening regional sales and new product launches; commemorative dividend planned for 30th anniversary.
Americas and China expected to see new product contributions in the second half; Japan to benefit from portfolio expansion.
Impact of US reciprocal tariffs expected to remain within ¥3.0–4.0 billion annually; Q1 impact minor.
Latest events from Sysmex
- Profits fell sharply as China and Japan sales dropped, offsetting robust growth in EMEA and Americas.6869
Q3 202612 Feb 2026 - Profits fell on lower sales in Japan and China, but global expansion and new business support growth.6869
Q2 202624 Nov 2025 - Record Q1 sales and profit growth driven by global reagent demand and new product launches.6869
Q1 202510 Sep 2025 - Sales and profits surged, prompting an upward revision to full-year guidance.6869
Q2 202513 Jun 2025 - Record sales and profit growth, with further gains and higher dividends forecast.6869
Q4 20256 Jun 2025 - Record sales and profit growth fueled by global demand and product innovation.6869
Q3 20255 Jun 2025